Kawasaki disease complicated by mild encephalopathy with a reversible splenial lesion (MERS)

Journal of the Neurological Sciences

Volumn 315, Issue 1-2, 2012, Pages 167-169

  Takanashi, Jun Ichi ^a,e   Shirai, Kentaro ^b   Sugawara, Yuji ^b   Okamoto, Yoko ^c   Obonai, Toshimasa ^d   Terada, Hitoshi ^e  

^a KAMEDA MEDICAL CENTER   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c Saitama Citizen Medical Center   (Japan)

^d Tokyo Metropolitan Health and Medical Treatment Corporation   (Japan)

^e TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

Author keywords

Cardiac aneurysm; Clinically mild encephalitis encephalopathy with a reversible splenial lesion (MERS); Corpus callosum; Delirium; Diffusion weighted image; Kawasaki disease

Indexed keywords

CYCLOSPORIN; IMMUNOGLOBULIN; INFLIXIMAB; PREDNISOLONE;

ARTICLE; BRAIN DISEASE; CASE REPORT; CHILD; DELIRIUM; DROWSINESS; ELECTROENCEPHALOGRAM; ENCEPHALITIS; FEMALE; FEVER; HEART ANEURYSM; HIGH RISK PATIENT; HUMAN; HYPONATREMIA; MALE; MILD ENCEPHALOPATHY WITH A REVERSIBLE SPLENIAL LESION; MUCOCUTANEOUS LYMPH NODE SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; PEDIATRICIAN; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT RESPONSE; WHITE MATTER;

CHILD; CHILD, PRESCHOOL; CORPUS CALLOSUM; ENCEPHALITIS; FEMALE; HUMANS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME;

EID: 84857995117     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.11.022     Document Type: Article

References (18)

1. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tana LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Pediatrics 2004;114:1708-33. (Pubitemid 41754943)
2. Burns JC, Glodé MP. Kawasaki disease. Lancet 2004;364:533-44.
3. Dengler LD, Capparelli EV, Bastian JF, Bradley DJ, Glode MP, Santa S, et al. Cerebrospinal fluid profile in patients with Kawasaki disease. Pediatr Infect Dis J 1998;17:478-81. (Pubitemid 28287612)
4. Terasawa K, Ichinose E, Matsuishi T, Kato H. Neurological complications in Kawasaki disease. Brain Dev 1983;5:371-4. (Pubitemid 13004403)
5. Yoshikawa H, Abe T. Febrile convulsion during the acute phase of Kawasaki disease. Pediatr Int 2004;46:31-2. (Pubitemid 38333626)
6. Tabarki B, Mahdhaoui A, Selmi H, Yacoub M, Essoussi AS. Kawasaki disease with predominant central nervous system involvement. Pediatr Neurol 2001;25:239-41. (Pubitemid 32913142)
7. Imai K, Kawabe Y, Awaya A, Asaka A. A case of Kawasaki disease accompanied by encephalopathy during acute phase (in Japanese). Jpn Soc Emerg Pediatr 2009;8:50-5.
8. Takanashi J. Two newly proposed encephalitis/encephalopathy syndromes. Brain Dev 2009;31:521-8.
9. Tada H, Takanashi J, Barkovich AJ, Oba H, Maeda M, Tsukahara H, et al. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion. Neurology 2004;63:1854-8. (Pubitemid 39532380)
10. Itamura S, Kamada M, Nakagawa N. Kawasaki disease complicated with reversible splenial lesion and acute myocarditis. Pediatr Cardiol 2011;32:696-9.
11. Sato T, Ushiroda Y, Oyama T, Nakatomi A, Motomura H, Moriuchi H. Kawasaki disease-associated with MERS: pathological insights from SPECT findings. Brain Dev 2011, doi:10.1016/j.braindev.2011.09.015.
12. Japan Kawasaki Disease Research Center. The 21th nationwide survey of Kawasaki disease in 2009-2010 (in Japanese). www.jichi.ac.jp/dph/kawasakibyou/ 20110915/mcls21report.pdf.
13. Takanashi J, Tada H, Maeda M, Suzuki M, Terada H, Barkovich AJ. Encephalopathy with a reversible splenial lesion is associated with hyponatremia. Brain Dev 2009;31:217-20.
14. Terai M, Honda T, Yasukawa K, Higashi K, Hamada H, Kohno Y. Prognostic impact of vascular leakage in acute Kawasaki disease. Circulation 2003;108:325-30. (Pubitemid 36899024)
15. Amano S, Hazama F. Neural involvement in Kawasaki disease. Acta Pathol Jpn 1980;30:365-73. (Pubitemid 11248072)
16. Muta H, Ishii M, Sakaue T, Egami K, Furui J, Sugahara Y, et al. Older age is a risk factor for the development of cardiovascular sequelae in Kawasaki disease. Pediatrics 2004;114:751-4. (Pubitemid 41529534)
17. Stockheim JA, Innocentini N, Shulman ST. Kawasaki disease in older children and adolescents. J Pediatr 2000;137:250-2. (Pubitemid 30659235)
18. Watanabe T, Abe Y, Sato S, Uehara Y, Ikeno K, Abe T. Hyponatermia in Kawasaki disease. Pediatr Nephrol 2006;21:778-81.